Cresco Labs Inc (CRLBF)
1.092
-0.06
(-5.00%)
USD |
OTCM |
Nov 22, 16:00
Cresco Labs Enterprise Value: 654.20M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 654.20M |
| November 21, 2024 | 674.19M |
| November 20, 2024 | 689.84M |
| November 19, 2024 | 698.53M |
| November 18, 2024 | 726.35M |
| November 15, 2024 | 757.64M |
| November 14, 2024 | 761.12M |
| November 13, 2024 | 775.03M |
| November 12, 2024 | 712.44M |
| November 11, 2024 | 635.94M |
| November 08, 2024 | 705.49M |
| November 07, 2024 | 719.36M |
| November 06, 2024 | 672.45M |
| November 05, 2024 | 803.37M |
| November 04, 2024 | 806.32M |
| November 01, 2024 | 801.11M |
| October 31, 2024 | 781.98M |
| October 30, 2024 | 795.89M |
| October 29, 2024 | 806.32M |
| October 28, 2024 | 823.71M |
| October 25, 2024 | 841.09M |
| October 24, 2024 | 843.07M |
| October 23, 2024 | 868.91M |
| October 22, 2024 | 865.43M |
| October 21, 2024 | 816.75M |
| Date | Value |
|---|---|
| October 18, 2024 | 827.18M |
| October 17, 2024 | 830.14M |
| October 16, 2024 | 820.23M |
| October 15, 2024 | 821.97M |
| October 14, 2024 | 844.57M |
| October 11, 2024 | 830.66M |
| October 10, 2024 | 841.09M |
| October 09, 2024 | 841.09M |
| October 08, 2024 | 844.57M |
| October 07, 2024 | 841.09M |
| October 04, 2024 | 844.57M |
| October 03, 2024 | 851.52M |
| October 02, 2024 | 844.57M |
| October 01, 2024 | 848.05M |
| September 30, 2024 | 855.00M |
| September 27, 2024 | 879.18M |
| September 26, 2024 | 889.61M |
| September 25, 2024 | 886.14M |
| September 24, 2024 | 903.52M |
| September 23, 2024 | 886.14M |
| September 20, 2024 | 861.80M |
| September 19, 2024 | 879.18M |
| September 18, 2024 | 875.71M |
| September 17, 2024 | 886.14M |
| September 16, 2024 | 896.57M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
492.58M
Minimum
Mar 18 2020
4.023B
Maximum
Feb 10 2021
1.529B
Average
1.171B
Median
Feb 18 2020
Enterprise Value Benchmarks
| MariMed Inc | 120.97M |
| cbdMD Inc | 0.7209M |
| Flora Growth Corp | 18.08M |
| NovaBay Pharmaceuticals Inc | 2.608M |
| Palatin Technologies Inc | 16.38M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.54M |
| Revenue (Quarterly) | 179.78M |
| Total Expenses (Quarterly) | 151.12M |
| EPS Diluted (Quarterly) | -0.03 |
| Gross Profit Margin (Quarterly) | 51.97% |
| Profit Margin (Quarterly) | -5.86% |
| Earnings Yield | -17.91% |
| Operating Earnings Yield | 31.20% |
| Normalized Earnings Yield | -17.68 |